Healthcare M&A Outlook in a Post-Pandemic World – Opportunities and Challenges

As the global pandemic is still spreading, 2020 has been a tough year for the global financial system. In the face of COVID-19, the global economy has suffered a huge impact. Although global cross-border M&A have been affected, the healthcare sector has attracted more attention and ushered in new industrial development opportunities. In the post-pandemic world, what new changes will happen in the healthcare industry? How can companies seize opportunities and meet the challenges ahead in such a rapidly changing external environment?

This workshop will focus on the hottest topics of leading technologies, international trends, investment directions and development opportunities in the healthcare sector in the post-pandemic world. We have gathered top experts in the industry to conduct in-depth discussions of hot sectors such as biomedicine and digital health so that investors can avoid some obvious minefields and seek stability and growth for their investments under the wave of the continuous development of the healthcare industry.

Agenda:

13:30 Registration 
14:00 Opening Speech
14:05 Keynote Speech 
14:35 Panel Discussion 
15:20 Networking

Speakers

See More
China

Rik Zhou

Sr. BD Director at Fosun Pharma
See More
China

Owen Huang

Partner at Deloitte China
See More
China

Chris Fang

Senior Director at Arctic Vision
See More
China

Dan Liu

Executive Director at CDH Investments
See More
China

John Yuan

Head of M&A Community China
See More
China

Xudong Tao

Partner at JunHe LLP

Get In Touch

Our team is happy to answer your questions. Fill out this form and we will get in touch with you.